reboxetine has been researched along with aripiprazole in 2 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (aripiprazole) | Trials (aripiprazole) | Recent Studies (post-2010) (aripiprazole) |
---|---|---|---|---|---|
626 | 193 | 184 | 2,989 | 509 | 1,788 |
Protein | Taxonomy | reboxetine (IC50) | aripiprazole (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 0.78 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0158 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 1.945 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.38 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.17 | |
Histamine H1 receptor | Homo sapiens (human) | 0.42 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.8572 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burrows, G; Jefferys, D | 1 |
Edlinger, M; Fleischhacker, W; Hofer, A; Seppi, K | 1 |
2 other study(ies) available for reboxetine and aripiprazole
Article | Year |
---|---|
Reversal of trichotillomania with aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Morpholines; Piperazines; Quinolones; Reboxetine; Self Concept; Sertraline; Social Adjustment; Trichotillomania | 2008 |
Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
Topics: Adult; Aggression; Antipsychotic Agents; Aripiprazole; Clozapine; Drug Therapy, Combination; Humans; Huntington Disease; Male; Morpholines; Piperazines; Psychotic Disorders; Quinolones; Reboxetine; Treatment Outcome | 2013 |